Inhibitor Therapeutics, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Inhibitor Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -40.6 %, a 141% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2023 was -30.6 %, a 108% decline from 2022.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2022 was 399 %.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2021 was -280 %, a 43.7% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -30.6 -430 -108% Jan 1, 2023 Dec 31, 2023
2022 399 +679 Jan 1, 2022 Dec 31, 2022
2021 -280 +218 +43.7% Jan 1, 2021 Dec 31, 2021
2020 -498 -309 -163% Jan 1, 2020 Dec 31, 2020
2019 -190 +103 +35.1% Jan 1, 2019 Dec 31, 2019
2018 -292 +2.98 +1.01% Jan 1, 2018 Dec 31, 2018
2017 -295 -126 -74.3% Jan 1, 2017 Dec 31, 2017
2016 -169 +163 +49.1% Jan 1, 2016 Dec 31, 2016
2015 -332 +996 +75% Jan 1, 2015 Dec 31, 2015
2014 -1.33K Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.